Effect of teaching pelvic floor muscle exercises on urinary incontinence after robot-assisted total prostatectomy (RARP)

JRCT ID: jRCT1040240171

Registered date:20/01/2025

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Prostate cancer
• Date of first enrollment: 01/03/2023
• Target sample size: 50
• Study type: Interventional

Intervention(s)

Consent for participation in the study will be obtained at the time of the decision on the date of total prostatectomy about 2 to 4 weeks prior to the day of surgery, and instruction in pelvic floor muscle exercises will begin at the same time.
Pelvic floor muscle exercises will then be taught during postoperative urinary catheter placement.
The patients' urinary drainage status will be checked at 1, 3, 6, and 12 months postoperatively.

The frequency of instruction should be given at the time of the patient's visit to the clinic, depending on the patient's preoperative and postoperative outpatient status.
The instruction, which was originally mainly given orally, will be given in a more practical manner under the guidance of a physical therapist.

Outcome(s)

• Primary Outcome: Postoperative incontinence

Secondary Outcome

Overall survival (OS)
Disease-free survival (DFS)
Progression-free survival (PFS)
Side effects
Quality of life (based on questionnaire)
Functional voiding as quantified by urodynamic testing
Intraoperative findings
Previous history
Comorbidities

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Male

Include criteria

Patients with a confirmed diagnosis of prostate cancer
Patients who underwent RARP
Patients who were instructed to perform pelvic floor muscle exercises before and after RARP
Patients who have given consent to participate in this study

Exclude criteria

Patients without a confirmed diagnosis of prostate cancer
Patients who can not perform pelvic floor muscle exercises
Patients who did not give consent to participate in this study (including patients in the control group who refused the use of their medical information in the study by opting out)
Patients whom the physician considers unlikely to participate in this study

Related Information

• Primary Sponsor: Takeuchi Shinichi